Essential Medicines Strategic Stockpile Act of 2023
Official title: To amend the Public Health Service Act to provide for stockpiles to ensure that all Americans have access to generic drugs at risk of shortage, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Essential Medicines Strategic Stockpile Act of 2023
This bill requires the Department of Health and Human Services (HHS) to create a pilot program to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.
To carry out the pilot program, HHS must enter into contracts for a term of up to three years with drug manufacturers, co-op or chain pharmacy warehouses, or other eligible entities to create a six-month stockpile of up to 50 types of such drugs.
The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 405: Essential Medicines Strategic Stockpile Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-405/
"H.R. 405: Essential Medicines Strategic Stockpile Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-405/.
H.R. 405, 118th Cong. (2026), https://openamerica.io/bill/118-HR-405/.
[H.R. 405: Essential Medicines Strategic Stockpile Act of 2023](https://openamerica.io/bill/118-HR-405/)